RetroSense Therapeutics' Series A - II Round

RetroSense Therapeutics raised a round of funding on August 31, 2015.

RetroSense Therapeutics is a privately-held biotechnology company developing life-enhancing gene therapies designed to restore vision in patients suffering from blindness due to retinitis pigmentosa (…

Articles about RetroSense Therapeutics' Series A - II Round: